News

November 2, 2023

|

Category:

Rare missense variants in protein intrinsically disordered regions: impact on condensates and common diseases

Poster presented at the American Society of Human Genetics Annual Meeting 2023

> Download the PDF file

Media Contact

media@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.

SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com

Back to News home section

Share:

Condensate-targeted drug discovery powered by phenotypic signatures

Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA

Home About us Science Pipeline Join us News Contact

Condensates.com

© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science